Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed May 14, 2020 · 10-Q · 44 days after period end · 0001564590-20-025275
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$3.32M | -$5.90M | -$3.02M | -$205.00K |
| EPS Diluted | -$2.15 | -$17.57 | -$2.43 | -$96.56 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 14, 2020 · 44 d after period end
